These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20483919)

  • 21. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAPPred prediction of TAP-binding peptides in antigens.
    Bhasin M; Lata S; Raghava GP
    Methods Mol Biol; 2007; 409():381-6. PubMed ID: 18450016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide binding to MHC class I and II proteins: new avenues from new methods.
    Yaneva R; Schneeweiss C; Zacharias M; Springer S
    Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative online prediction of peptide binding to the major histocompatibility complex.
    Hattotuwagama CK; Guan P; Doytchinova IA; Zygouri C; Flower DR
    J Mol Graph Model; 2004 Jan; 22(3):195-207. PubMed ID: 14629978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.
    Bhasin M; Raghava GP
    J Biosci; 2007 Jan; 32(1):31-42. PubMed ID: 17426378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EpiTOP--a proteochemometric tool for MHC class II binding prediction.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Bioinformatics; 2010 Aug; 26(16):2066-8. PubMed ID: 20576624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of MHC class I binding peptides using profile motifs.
    Reche PA; Glutting JP; Reinherz EL
    Hum Immunol; 2002 Sep; 63(9):701-9. PubMed ID: 12175724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do class I MHC molecules bind smaller peptides than class II MHC molecules?
    Blanden RV
    Immunol Cell Biol; 1995 Feb; 73(1):95-7. PubMed ID: 7768550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Building a meta-predictor for MHC class II-binding peptides.
    Huang L; Karpenko O; Murugan N; Dai Y
    Methods Mol Biol; 2007; 409():355-64. PubMed ID: 18450014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemistry of peptides associated with MHC class I and class II molecules.
    Rammensee HG
    Curr Opin Immunol; 1995 Feb; 7(1):85-96. PubMed ID: 7772286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHCPEP: a database of MHC-binding peptides.
    Brusic V; Rudy G; Harrison LC
    Nucleic Acids Res; 1994 Sep; 22(17):3663-5. PubMed ID: 7937075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune epitope database analysis resource.
    Kim Y; Ponomarenko J; Zhu Z; Tamang D; Wang P; Greenbaum J; Lundegaard C; Sette A; Lund O; Bourne PE; Nielsen M; Peters B
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W525-30. PubMed ID: 22610854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.
    Karosiene E; Lundegaard C; Lund O; Nielsen M
    Immunogenetics; 2012 Mar; 64(3):177-86. PubMed ID: 22009319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.
    Lin HH; Zhang GL; Tongchusak S; Reinherz EL; Brusic V
    BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S22. PubMed ID: 19091022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHCII3D-Robust Structure Based Prediction of MHC II Binding Peptides.
    Laimer J; Lackner P
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide interactions with class I and II MHC encoded molecules.
    Pecht I
    Isr J Med Sci; 1994 Mar; 30(3):28-31. PubMed ID: 7514162
    [No Abstract]   [Full Text] [Related]  

  • 39. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods.
    Zhang H; Lundegaard C; Nielsen M
    Bioinformatics; 2009 Jan; 25(1):83-9. PubMed ID: 18996943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.